Search

Your search keyword '"HCM"' showing total 696 results

Search Constraints

Start Over You searched for: Descriptor "HCM" Remove constraint Descriptor: "HCM"
696 results on '"HCM"'

Search Results

51. Evaluación de la influencia de las motocicletas en el nivel de servicio de las intersecciones semaforizadas más accidentadas en Bogotá.

52. Prognostic value of global longitudinal strain in hypertrophic cardiomyopathy: A systematic review and meta‐analysis.

53. Function Generation Synthesis of the Four-bar Linkage Based on Four and Five Precision Points using Newton-HCM.

54. Retrospective evaluation of hypertrophic cardiomyopathy in 68 dogs

55. Unveiling MiRNA-124 as a biomarker in hypertrophic cardiomyopathy: An innovative approach using machine learning and intelligent data analysis.

56. Development of ventricular cell models for the study of alternans, heart failure and energetic impairment

57. AS and HCM

59. Extended septal myectomy using a combined trans-aortic and apical approach for long basal and mid-cavity hypertrophic cardiomyopathy.

60. Systemic Biomarkers and Unique Pathways in Different Phenotypes of Heart Failure with Preserved Ejection Fraction.

61. Epigenetic Study of Cohort of Monozygotic Twins With Hypertrophic Cardiomyopathy Due to MYBPC3 (Cardiac Myosin-Binding Protein C).

62. Detection of Left Atrial Remodeling by Three-Dimensional Echocardiography in Symptomatic Patients Known to Had Non-Obstructive Hypertrophic Cardiomyopathy.

63. Association Between Parathyroid Hormone-Related Peptide Levels and Mortality in Patients With Malignancy.

64. Comparison of Drug Therapy Efficacy in Patients With Hypertrophic Cardiomyopathy: A Network Meta-Analysis.

65. A New Model to Evaluate Percent-Time-Spent-Following on Two-Lane Highways

66. Using HCM Method in Estimation the Highway Capacity and Recommendation Traffic Management for a Section of National Highway #5 - VietNam

67. Transcriptome Profile Identifies Actin as an Essential Regulator of Cardiac Myosin Binding Protein C3 Hypertrophic Cardiomyopathy in a Zebrafish Model.

68. Regulation of SMAD Signaling Pathway by miRNAs Associated with Myocardial Fibrosis: In silico Analysis of Target Gene Networks.

69. Characterization of cardiac metabolism in iPSC-derived cardiomyocytes: lessons from maturation and disease modeling.

70. Identification of Underlying Hub Genes Associated with Hypertrophic Cardiomyopathy by Integrated Bioinformatics Analysis

71. Sepsis-induced suicidal left ventricular in a patient with hypertrophic cardiomyopathy/hypertrophic obstructive cardiomyopathy

72. Automated three‐dimensional echocardiographic quantification for left ventricular volume and function in patients with hypertrophic cardiomyopathy.

73. Retrospective evaluation of hypertrophic cardiomyopathy in 68 dogs.

74. Whole mitochondrial genome sequencing of Malaysian patients with cardiomyopathy.

75. Acute pharmacodynamic effects of pimobendan in client-owned cats with subclinical hypertrophic cardiomyopathy

76. Pedestrian walking speed at un-signalized midblock crosswalk and its impact on urban street segment performance

77. Genetic determinants of clinical phenotype in hypertrophic cardiomyopathy

78. Contrast-free detection of myocardial fibrosis in hypertrophic cardiomyopathy patients with diffusion-weighted cardiovascular magnetic resonance.

79. Hypertrophic cardiomyopathy (HCM) and hypertensive heart disease (HHD) diagnosis using echocardiography and electrocardiography.

80. FK506-Binding Protein like (FKBPL) Has an Important Role in Heart Failure with Preserved Ejection Fraction Pathogenesis with Potential Diagnostic Utility

81. Genetic Basis of Hypertrophic Cardiomyopathy in Cats.

82. Discontinuation of afterload-reducing drugs decreases left ventricular outflow tract obstruction in hypertrophic obstructive cardiomyopathy.

83. Atrial Fibrillation Substrate and Catheter Ablation Outcomes in MYBPC3- and MYH7-Mediated Hypertrophic Cardiomyopathy.

84. A cost-effectiveness analysis of hypertrophic cardiomyopathy sudden cardiac death risk algorithms for implantable cardioverter defibrillator decision-making.

85. Olfactory schwannoma with hypertrophic cardiomyopathy: incidental association?

86. The modified US heart allocation system improves transplant rates and decreases status upgrade utilization for patients with hypertrophic cardiomyopathy.

87. Low-intensity late gadolinium enhancement predominates in hypertrophic cardiomyopathy.

89. Systemic Biomarkers and Unique Pathways in Different Phenotypes of Heart Failure with Preserved Ejection Fraction

90. Avaliação do efeito de faixas adicionais de subida em segmentos de rodovias de pista simples

91. Cardiac MRI findings to differentiate athlete's heart from hypertrophic (HCM), arrhythmogenic right ventricular (ARVC) and dilated (DCM) cardiomyopathy.

92. Mavacamten, a Novel Therapeutic Strategy for Obstructive Hypertrophic Cardiomyopathy.

93. Sepsis-Induced Suicidal Left Ventricular in a Patient with Hypertrophic Cardiomyopathy/Hypertrophic Obstructive Cardiomyopathy.

94. Calibrating HCM model for roundabout entry capacity under heterogeneous traffic

95. Transcriptome Profile Identifies Actin as an Essential Regulator of Cardiac Myosin Binding Protein C3 Hypertrophic Cardiomyopathy in a Zebrafish Model

96. Managing the Learning Capacity of Organizational Culture in Relation to Organizational Commitment: Methodological and Empirical Overview

97. Multi-omics integration identifies key upstream regulators of pathomechanisms in hypertrophic cardiomyopathy due to truncating MYBPC3 mutations.

98. High ECG Risk-Scores Predict Late Gadolinium Enhancement on Magnetic Resonance Imaging in HCM in the Young.

99. ACE Genotype Distributions Differ between Sporadic and Familial Hypertrophic Cardiomyopathy

100. Acute pharmacodynamic effects of pimobendan in client-owned cats with subclinical hypertrophic cardiomyopathy.

Catalog

Books, media, physical & digital resources